The increased expression of Ccnd2 (cyclin D2) is discordant with enhanced tumorigenesis of early continuous HFD and HFD-LFD tumors, as loss of cyclin D2 expression is frequent in breast cancers [30] and cyclin D2 has been considered to be a tumor suppressor. This evidence concerns the gene CCND2 and breast carcinoma.